Author

J. M. Sepulveda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Hernandez-Lain· 1 shared A. Perez-Nunez· 1 shared B. Segura-Collar· 1 shared C. Blanco-Aparicio· 1 shared C. Nör· 1 shared D. Megias· 1 shared D. Retana· 1 shared E. Caleiras· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hernandez-Lain

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

On optimal temozolomide scheduling for slowly growing gliomas

B. Segura-Collar, J. Jimenez-Sanchez, R. Gargini, M. Dragoj, J. M. Sepulveda, M. Pesic, P. Sanchez-Gomez, V. M. Perez-Garcia

This study uses in-silico models and experimental data to show that longer TMZ dose intervals improve survival and reduce toxicity in slowly growing gliomas by altering tumor phenotype.

bioRxiv · Mar 10, 2022 · PreprintCancer Biology

A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis

L. Zhu, N. Yebra, D. Retana, L. Miarka, E. Hernandez-Encinas, C. Blanco-Aparicio, S. Martinez, R. Soffietti, L. Bertero, P. Cassoni, T. Weiss, J. Munoz, J. M. Sepulveda, A. Perez-Nunez, A. Hernandez-Lain, , M. Valiente

The paper introduces a drug-screening platform using organotypic cultures to identify effective treatments for brain metastasis, finding a potent HSP90 inhibitor that works against mouse and human metastases.

bioRxiv · Oct 16, 2020 · PreprintCancer Biology